AKT1 and cancer: A study done by Kazerounian et al. demonstrated that RhoB differentially controls AKT function in tumor versus endothelial cells, resulting in decreased proliferation of early stage cancer that was superseded by the proangiogenic functions of RhoB in endothelial cells during tumor progression [61].